Goldman Sachs analyst David Roman initiates coverage on $HealthEquity (HQY.US)$ with a hold rating, and sets the target price at $108.
According to TipRanks data, the analyst has a success rate of 57.1% and a total average return of 4.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $HealthEquity (HQY.US)$'s main analysts recently are as follows:
HealthEquity is perceived as 'one of the most secure digital health investments', due to the company's robust execution and commanding position in the industry. The reassessment of the company's valuation multiple has been influenced by more stable five-year treasury rates.
The firm's optimism towards HealthEquity is rooted in improving policy fundamentals, enhanced visibility into demand trends, and a robust economy and labor market. These factors are incorporated into their updated business outlook. Furthermore, as health-tech and services increasingly pivot towards consumer-facing digital products, the anticipated leadership of incoming CEO Scott Cutler is expected to spearhead further growth.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
高盛集團分析師David Roman首次給予$HealthEquity (HQY.US)$持有評級，目標價108美元。
根據TipRanks數據顯示，該分析師近一年總勝率為57.1%，總平均回報率為4.1%。
此外，綜合報道，$HealthEquity (HQY.US)$近期主要分析師觀點如下：
HealthEquity被視爲 「最安全的數字健康投資之一」，這要歸因於該公司的強勁執行力和行業領先地位。對公司估值倍數的重新評估受到了更穩定的五年期國債利率的影響。
該公司對HealthEquity的樂觀情緒源於政策基本面改善、需求趨勢可見度提高以及經濟和勞動力市場強勁。這些因素已納入他們最新的業務展望中。此外，隨着健康科技和服務越來越多地轉向面向消費者的數字產品，即將上任的首席執行官斯科特·卡特勒的預期領導層預計將帶動進一步增長。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
